Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. Home/
    2. Media Center/
    3. Press releases /
    4. Innovative Medicine

    Innovative Medicine

    Innovative Medicine
    November 4, 2013

    Simeprevir Administered Once Daily as Part of Combination Therapy Demonstrates Sustained Virologic Response in Treatment-Naïve and Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients

    Learn more
    Innovative Medicine
    November 1, 2013

    INCIVO® (TELAPREVIR) Anti-Viral Response, Safety, Tolerability And Cost-Effectiveness Data To Be Presented At AASLD And ISPOR, Two International Congresses

    Learn more
    Innovative Medicine
    October 30, 2013

    New Marketing Authorisation Application Submitted to EMA for Ibrutinib for the Treatment of Two Forms of Blood Cancer

    The submission is for chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) and mantle cell lymphoma (MCL), two difficult-to-treat diseases
    Learn more
    Innovative Medicine
    October 28, 2013

    New STELARA® Data Show Inhibition Of Joint Destruction In Patients With Active Psoriatic Arthritis

    Integrated Analysis of Two Pivotal Phase 3 Studies Showed STELARA Inhibited the Progression of Structural Damage at Week 24, and Demonstrated Continued Inhibition through Two Years
    Learn more
    Innovative Medicine
    October 28, 2013

    New Two-Year Results Show SIMPONI® ARIA™ (GOLIMUMAB) For Infusion Inhibited Radiographic Progression In Patients With Active Rheumatoid Arthritis

    Nearly 70 Percent of Patients Receiving SIMPONI ARIA at Two Years Demonstrated ACR 20 Response
    Learn more
    Innovative Medicine
    October 24, 2013

    FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients

    Learn more
    Innovative Medicine
    October 15, 2013

    Janssen Submits Marketing Authorisation Application to European Medicines Agency for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat

    Learn more
    Innovative Medicine
    October 8, 2013

    Janssen Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C from GlaxoSmithKline

    Learn more
    Innovative Medicine
    October 7, 2013

    Simeprevir Data from COSMOS study in Hepatitis C Patients Accepted as Late-Breaking Presentation at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

    Learn more
    Load more